In 2012, the 2005 WHO criteria and classification system of neuroendocrine tumors of the head and neck region was modified by adding the ranges of the Ki-67–labeling index and mitotic count and suggested that LCNEC should be considered a distinct disease entity and be separated from AC [2]. The gene discussed is MKI67; the disease is neuroendocrine neoplasm.